Avalo Therapeutics, Inc. · NASDAQ:AVTX
Silverarc Capital Management, LLC reported a 5.48% stake in Avalo Therapeutics, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Silverarc Capital Management, LLC reported a 5.48% stake in Avalo Therapeutics, Inc., 720,922 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 5.48%
- Shares
- 720,922
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SilverArc Capital Management, LLC | 5.48% | 720,922 |
| Devesh Gandhi | 5.48% | 720,922 |
Source
Related
- Avalo Therapeutics, Inc.
- Silverarc Capital Management, LLC
- Avalo Therapeutics, Inc. shareholders
- Schedule 13G · Silverarc Capital Management, LLC · Feb 10, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026